Saturday 17 October 2026
Export RCEL’s income statement to Excel — free account
Avita Medical Inc.
RCEL Healthcare Medical Devices
Avita Medical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $71.6 million, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 17.8%, EPS grew 33.8%, free cash flow grew 66.5% and total debt rose 10.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
13.04
0.37
−2.76%
Follow RCEL
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 3 | 3 | 3 |
| (1,746.27%) | 799.72% | 326.92% | 211.55% | ||
| (67.07%) | (71.40%) | (74.88%) | (81.36%) | ||
ROIC |
(211.01%) | (334.18%) | (288.05%) | (306.20%) | |
Return on Tangible Assets |
458.93% | 261.83% | 169.09% | 131.98% | |
Average Days of Receivables |
45.44 | 46.31 | 49.87 | 47.62 | |
Free Cash Flow per Share |
(26.15) | (23.57) | (21.22) | (16.42) | |
Free Cash Flow |
(37.13) | (32.83) | (32.40) | (25.25) | |
Capital Expenditures |
(3.29) | (1.64) | (1.44) | (1.02) | |
| Other line items | |||||
Cash ROIC |
(62.83%) | (73.76%) | (87.01%) | (84.28%) | |
Accounts Receivable Turnover |
7.46 | 6.86 | 6.60 | 7.13 | |
Accounts Payable Turnover |
1.91 | 1.68 | 1.70 | 2.04 | |
Inventory Turnover |
1.75 | 1.80 | 1.86 | 2.18 | |
Average Days of Payables |
251.43 | 255.59 | 195.44 | 168.06 | |
Days of Inventory on Hand |
224.54 | 197.59 | 165.58 | 138.33 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
27.62% | 29.10% | 27.90% | 26.64% | |
Selling, General and Administrative Expense of Revenue |
114.25% | 112.43% | 108.07% | 101.48% | |
Share Based Compensation of Revenue |
15.12% | 13.29% | 10.96% | 9.57% | |
Interest Coverage |
(6.78) | (8.71) | (7.73) | (6.97) | |
Operating CF/Net income |
0.70 | 0.64 | 0.68 | 0.56 | |
Depreciation/Fixed assets |
0.21 | 0.27 | 0.30 | 0.33 | |
Capex/Depreciation |
(1.60) | (0.70) | (0.59) | (0.41) | |
Revenue per Share |
51.00 | 51.41 | 47.38 | 49.19 | |
Operating CF per Share |
(23.83) | (22.39) | (20.27) | (15.76) | |
Capex per Share |
(2.32) | (1.18) | (0.94) | (0.66) | |
Capex to Sales |
0.05 | 0.02 | 0.02 | 0.01 |
Columns are period end dates